Salk researchers show how two experimental Alzheimer’s drugs protect the brains of mice from other aspects of aging
In mouse models of Alzheimer’s disease, the investigational drug candidates known as CMS121 and J147 improve memory and slow the degeneration of brain cells. Now, Salk researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain cells that normally occurs during aging and restoring the levels of specific molecules to those seen in younger brains.
The research, published last month in the journal eLife, suggests that the drug candidates may be useful for treating a broader array of conditions and points out a new pathway that links normal aging to Alzheimer’s disease.
“This study further validated these two compounds not only as Alzheimer’s drug candidates but also as potentially more widely useful for their anti-aging effects,” says Pamela Maher, a senior staff scientist at Salk and a co-corresponding author of the new paper.
Old age is the biggest risk factor for Alzheimer’s disease—above the age of 65, a person’s risk of developing the disease doubles about every five years. However, at a molecular level, scientists aren’t sure what occurs in the brain with aging that contributes to Alzheimer’s.
“The contribution of old age-associated detrimental processes to the disease has been largely neglected in Alzheimer’s disease drug discovery,” says Antonio Currais, a Salk staff scientist and first author of the new paper.
Maher and David Schubert, the head of Salk’s Cellular Neurobiology Lab, previously developed CMS121 and J147, variants of plant compounds with medicinal properties. Both compounds tested positive for their ability to keep neurons alive when exposed to cellular forms of stress related to aging and Alzheimer’s disease. Since then, the researchers have used the drug candidates to treat Alzheimer’s in animal models of the disease. But experiments revealing exactly how the compounds work suggested that they were targeting molecular pathways also known to be important in longevity and aging.
In the new research, Maher, Currais and their colleagues turned to a strain of mice that ages unusually fast. A subset of these mice was given CMS121 or J147 beginning at nine months old—the equivalent of late middle age in humans. After four months, the team tested the memory and behavior of the animals and analyzed genetic and molecular markers in their brains.
Not only did the animals given either of the drug candidates perform better on memory tests than mice that hadn’t received any treatment, but their brains showed differences at the cellular and molecular levels. In particular, expression of genes associated with the cell’s energy-generating structures called mitochondria was preserved by CMS121 and J147 with aging.
“The bottom line was that these two compounds prevent molecular changes that are associated with aging,” says Maher.
More detailed experiments showed that both drugs affected mitochondria by increasing levels of the chemical acetyl-coenzyme A (acetyl-coA). In isolated brain cells, when the researchers blocked an enzyme that normally breaks down acetyl-CoA, or when they added extra amounts of an acetyl-coA precursor, they saw the same beneficial effect on mitochondria and energy generation. The brain cells became protected against the normal molecular changes associated with aging.
“There was already some data from human studies that the function of mitochondria is negatively impacted in aging and that it’s worse in the context of Alzheimer’s,” says Maher. “This helps solidify that link.”
Maher and Currais are planning future experiments to test the effects of CMS121 and J147 on how other organs age. They also hope to use the new results to inform the development of new Alzheimer’s drugs; targeting other molecules in the acetyl-coA pathway may help treat the disease, they hypothesize.
“We are now using a variety of animal models to investigate how this neuroprotective pathway regulates specific molecular aspects of mitochondrial biology, and their effects on aging and Alzheimer’s,” says Currais.
Go deeper with Bing News on:
- Australia to refit ageing submarines as doubts over new French fleet growon June 10, 2021 at 6:39 pm
CANBERRA: Australia will refurbish its ageing Collins-class submarine fleet, The Australian newspaper reported on Friday (Jun 11), as doubts over ...
- Australia to refit ageing submarines as doubts over new French fleet grow, says reporton June 10, 2021 at 6:12 pm
Australia will refurbish its ageing Collins-class submarine fleet, The Australian newspaper reported today, as doubts over Canberra's A$50 billion (RM159.6 billion) deal for 12 new submarines built by ...
- Australia to Refit Ageing Submarines as Doubts Over New French Fleet Grow - the Australianon June 10, 2021 at 6:12 pm
Australia will refurbish its ageing Collins-class submarine fleet, The Australian newspaper reported on Friday, as doubts over Canberra's A$50 billion ($38.8 billion) deal for 12 new submarines built ...
- $10bn refit for ageing Collins-class submarines amid China concernson June 10, 2021 at 5:38 am
All six of the navys Collins-class submarines will be completely rebuilt to extend their life for another decade, under an ambitious, high-risk plan to safeguard the nations submarine capability in ...
- Why blue light from excess screen time could be a pocket-sized sun ageing your skinon June 10, 2021 at 3:36 am
On average Britons spend 45 hours a week gawping at their devices but there are fears it could be straining more than just our eyes ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Mayo Clinic, U of M researchers target biology of aging for potential COVID-19 treatmenton June 10, 2021 at 6:22 pm
New research from Mayo Clinic and University of Minnesota Medical School reveals a potential treatment for those most vulnerable to COVID-19.
- The future of aging in Canadaon June 10, 2021 at 6:05 pm
As the co-chair for the Federal, Provincial, and Territorial (FPT) Ministers Responsible for Seniors Forum, it was my pleasure to join Honourable Deb Schulte, federal Minister of Seniors, to represent ...
- This Classic $28 Moisturizer Protects You From the Sun and Treats Signs of Agingon June 10, 2021 at 11:46 am
Moisturizer delivers protection from the sun and hydration, staving off signs of aging while keeping your skin looking fresh. Among the moisturizer's ingredients is niacinamide, a water-soluble ...
- Brooke Shields’ Go-To Anti-Aging Brand Just Dropped a Brightening Sunscreenon June 10, 2021 at 10:34 am
Brooke Shields loves SkinCeuticals, and the brand just dropped a brand new daily brightening SPF for the summer — details ...
- VitalityMDs Aesthetics offers advanced beauty and anti-aging treatmentson June 10, 2021 at 9:17 am
((SL Advertiser)) To book an appointment at VitalityMDs Aesthetics call (480) 291-6321 or text (480) 673-8215 or log onto VitalityMDs.com ...